SecBot SecBot
EFFECT ·Filed Jul 20, 2026

VNRX

VOLITIONRX LTD
BEARISH
Impact 6/10
Horizonimmediate Processed3mo ago SEC9999999995-26-002355
IPO/offering going effective
Actionable Insight ▼ Bearish

Expect immediate downward pressure as selling stockholders may begin selling into the market. Monitor volume and price action for signs of distribution. The overhang will persist until the shelf is exhausted or expires.

DirectionBearish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VNRX ▼ -83.65% at T+60d
SHORT call ✓ call won +83.65% · α vs SPY +88.50% · entry $1.13 → $0.1847
Entry = T+0 close
Jul 20, 2026
via day close
T+1d
-1.77%
call +1.77% · α +2.60%
$1.11
settled 3mo ago
T+5d
-22.12%
call +22.12% · α +21.72%
$0.8800
settled 3mo ago
T+20d
-55.75%
call +55.75% · α +59.87%
$0.5000
settled 2mo ago
T+60d
-83.65%
call +83.65% · α +88.50%
$0.1847
settled 15d ago

Price Chart

Loading chart...

Executive Summary

VolitionRx's S-3 shelf registration became effective on July 17, 2026, allowing selling stockholders to immediately resell up to 17,968,090 shares. The company receives no proceeds. With a market cap of ~$13M, this represents massive potential dilution and creates a significant overhang on the stock.

Key Facts

  • S-3 registration (File No. 333-297402) declared effective on 2026-07-17
  • Up to 17,968,090 shares may be resold by selling stockholders
  • Shares include 483,870 from private placement, up to 10,000,000 from convertible note conversion, and up to 7,484,220 from warrant exercise
  • Company receives no proceeds from any sales
  • Market cap is approximately $13M, making potential dilution severe

Financial Impact

Potential dilution of up to 17.97M shares vs ~$13M market cap; no proceeds to company

dilutionshare price

Risk Factors

  • Massive dilution if all shares are sold
  • Selling pressure from note conversion and warrant exercise
  • No new capital raised to offset dilution

Market Snapshot

Exchange
NYSE
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002355
Document: 9999999995-26-002355-index.html9999999995-26-002355
Document: 9999999995-26-002355.txt9999999995-26-002355
20 reports for VNRX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VNRX — sortable, filterable
TypeNow
Oct 27, 2026
today
8-K
NEUTRAL ★ 4/10
$0.1900awaiting T+60—$0.1900 (−0.00%)
Sep 25, 2026
4w ago
8-K
BEARISH ★ 7/10
$0.2529awaiting T+60—$0.1900 (+24.87%)
Sep 16, 2026
5w ago
SC 13D/A
NEUTRAL ★ 3/10
$0.2849awaiting T+60—$0.1900 (−33.31%)
Sep 15, 2026
6w ago
8-K
BEARISH ★ 5/10
$0.2749awaiting T+60—$0.1900 (+30.88%)
Sep 11, 2026
6w ago
EFFECT
BEARISH ★ 7/10
$0.3102awaiting T+60—$0.1900 (+38.75%)
Sep 8, 2026
7w ago
S-3/A
BEARISH ★ 7/10
$0.3400awaiting T+60—$0.1900 (+44.12%)
Sep 1, 2026
8w ago
8-K
BEARISH ★ 6/10
$0.3800awaiting T+60—$0.1900 (+50.00%)
Aug 24, 2026
9w ago
8-K
BEARISH ★ 6/10
$0.3846awaiting T+60—$0.1900 (+50.60%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 6/10
$0.7700awaiting T+60—$0.1900 (+75.32%)
Jul 20, 2026
14w ago
EFFECT
BEARISH ★ 6/10
$1.13 $0.1847▲ +83.65%▲ +88.50%$0.1900 (+83.19%)
Showing 10 of 20

US Market Status

Market Closed — Opens Thu (10h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 20, 2026